OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 144 filers reported holding OPHTHOTECH CORP in Q4 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $27,000 | -80.0% | 10,000 | -79.1% | 0.00% | -100.0% |
Q3 2017 | $135,000 | -35.4% | 47,960 | -41.3% | 0.00% | 0.0% |
Q2 2017 | $209,000 | -76.3% | 81,760 | -66.0% | 0.00% | -83.3% |
Q1 2017 | $881,000 | +36.2% | 240,600 | +79.6% | 0.01% | +20.0% |
Q4 2016 | $647,000 | +16075.0% | 133,971 | +133871.0% | 0.01% | – |
Q3 2015 | $4,000 | -75.0% | 100 | -66.7% | 0.00% | – |
Q2 2015 | $16,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JHL Capital Group LLC | 3,265,000 | $166,613,000 | 20.59% |
Novo Holdings A/S | 3,610,487 | $184,243,000 | 19.34% |
Green Owl Capital Management, LLC | 847 | $834,000 | 5.16% |
Ghost Tree Capital, LLC | 215,000 | $10,971,000 | 3.17% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $822,000 | 2.76% |
IMA Wealth, Inc. | 57,131 | $2,867,000 | 1.80% |
Slate Path Capital LP | 430,000 | $21,943,000 | 1.72% |
Signpost Capital Advisors, LP | 50,587 | $2,581,000 | 1.36% |
Orbimed Advisors | 2,148,100 | $109,618,000 | 1.14% |
PURA VIDA INVESTMENTS, LLC | 52,500 | $2,679,000 | 1.14% |